Mo1152 The Role of Cancer Stem Cells in the Increased Risk of Colorectal Cancer in African-Americans

2014 ◽  
Vol 146 (5) ◽  
pp. S-571
Author(s):  
Fadi Antaki ◽  
Lulu Farhana ◽  
Lawrence A. Miller ◽  
Mohammad R. Anees ◽  
Yingjie Yu ◽  
...  
Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 2936 ◽  
Author(s):  
Federica Francescangeli ◽  
Maria Laura De Angelis ◽  
Ann Zeuner

Colorectal cancer (CRC) is the third commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Global CRC burden is expected to increase by 60% in the next decade, with low-income countries experiencing an escalation of CRC incidence and mortality in parallel to the adoption of western lifestyles. CRC incidence is also sharply increasing in individuals younger than 50 years, often presenting at advanced stages and with aggressive features. Both genetic and environmental factors have been recognized as major contributors for the development of CRC, the latter including diet-related conditions such as chronic inflammation and obesity. In particular, a diet rich in fat and sugars (Western-style diet, WSD) has been shown to induce multiple pathophysiological changes in the intestine linked to an increased risk of CRC. In this scenario, dietary factors have been recently shown to play novel unexpected roles in the regulation of intestinal stem cells (ISCs) and of the gut microbiota, which represent the two main biological systems responsible for intestinal homeostasis. Furthermore, diet is increasingly recognized to play a key role in the neoplastic transformation of ISCs and in the metabolic regulation of colorectal cancer stem cells. This review illustrates novel discoveries on the role of dietary components in regulating intestinal homeostasis and colorectal tumorigenesis. Particular focus is dedicated to new areas of research with potential clinical relevance including the effect of food components on ISCs and cancer stem cells (CSCs), the existence of CRC-specific microbial signatures and the alterations of intestinal homeostasis potentially involved in early-onset CRC. New insights on the role of dietary factors in intestinal regulation will provide new tools not only for the prevention and early diagnosis of CRC but also for improving the effectiveness of current CRC therapies.


2021 ◽  
Author(s):  
Mingli Yang ◽  
Thomas B. Davis B. Davis ◽  
Michael V. Nebozhyn ◽  
Andrey Loboda ◽  
Heiman Wang ◽  
...  

2020 ◽  
pp. 1-8
Author(s):  
Nilesh Kumar Sharma ◽  
Sachin C. Sarode ◽  
Gargi S Sarode ◽  
Shankargouda Patil ◽  
Jayanta K. Pal

2013 ◽  
Vol 4 (3) ◽  
pp. 241-250 ◽  
Author(s):  
Russell C. Langan ◽  
John E. Mullinax ◽  
Manish T. Raiji ◽  
Trevor Upham ◽  
Thomas Summers ◽  
...  

Cancers ◽  
2011 ◽  
Vol 3 (1) ◽  
pp. 319-339 ◽  
Author(s):  
Eric C. Anderson ◽  
Crystal Hessman ◽  
Trevor G. Levin ◽  
Marcus M. Monroe ◽  
Melissa H. Wong

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Sébastien Relier ◽  
Julie Ripoll ◽  
Hélène Guillorit ◽  
Amandine Amalric ◽  
Cyrinne Achour ◽  
...  

AbstractCancer stem cells (CSCs) are a small but critical cell population for cancer biology since they display inherent resistance to standard therapies and give rise to metastases. Despite accruing evidence establishing a link between deregulation of epitranscriptome-related players and tumorigenic process, the role of messenger RNA (mRNA) modifications in the regulation of CSC properties remains poorly understood. Here, we show that the cytoplasmic pool of fat mass and obesity-associated protein (FTO) impedes CSC abilities in colorectal cancer through its N6,2’-O-dimethyladenosine (m6Am) demethylase activity. While m6Am is strategically located next to the m7G-mRNA cap, its biological function is not well understood and has not been addressed in cancer. Low FTO expression in patient-derived cell lines elevates m6Am level in mRNA which results in enhanced in vivo tumorigenicity and chemoresistance. Inhibition of the nuclear m6Am methyltransferase, PCIF1/CAPAM, fully reverses this phenotype, stressing the role of m6Am modification in stem-like properties acquisition. FTO-mediated regulation of m6Am marking constitutes a reversible pathway controlling CSC abilities. Altogether, our findings bring to light the first biological function of the m6Am modification and its potential adverse consequences for colorectal cancer management.


2016 ◽  
Vol 5 (6) ◽  
pp. 1268-1278 ◽  
Author(s):  
Lulu Farhana ◽  
Fadi Antaki ◽  
Mohammad R. Anees ◽  
Pratima Nangia‐Makker ◽  
Stephanie Judd ◽  
...  

2016 ◽  
Author(s):  
Chia-Nung Hung ◽  
Ching-Yu Chang ◽  
Jou Hsiao ◽  
Wan-Chen Wei ◽  
Wei-Ting Chao

2012 ◽  
Vol 3 ◽  
pp. 231-240 ◽  
Author(s):  
Russell C. Langan ◽  
John E. Mullinax ◽  
Satyajit Ray ◽  
Manish T. Raiji ◽  
Nicholas Schaub ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document